search
Back to results

Lumen-apposing Metal Stent With or Without Coaxial Plastic Stent for Treatment of Walled-off Pancreatic Necrosis

Primary Purpose

Pancreatitis, Acute Necrotizing, Walled Off Necrosis

Status
Completed
Phase
Not Applicable
Locations
Czechia
Study Type
Interventional
Intervention
EUS-guided drainage using LAMS with DPS
EUS-guided drainage using LAMS alone
Sponsored by
Palacky University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pancreatitis, Acute Necrotizing focused on measuring Walled off necrosis, Acute pancreatitis, Necrotizing pancreatitis, Endoscopic drainage, Lumen apposing metal stents, Double pigtail plastic stent

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • walled-off pancreatic necrosis (WON) indicated for endoscopical drainage
  • signed informed consent form

Exclusion Criteria:

  • patient disagreement with the study
  • types of collections other than WON
  • drainage with stents other than LAMS
  • previous attempts at drainage of WON
  • severe coagulopathy or thrombocytopenia

Sites / Locations

  • University Hospital Olomouc, Second Department of Internal Medicine - Gastroenterology and Geriatrics

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

LAMS plus DPS

LAMS alone

Arm Description

Endoscopic ultrasound-guided (EUS) transmural drainage of walled-off pancreatic necrosis (WON) using lumen-apposing metal stent (LAMS) with coaxial double-pigtail plastic stent (DPS).

Endoscopic ultrasound-guided (EUS) transmural drainage of walled-off pancreatic necrosis (WON) using lumen-apposing metal stent (LAMS) alone.

Outcomes

Primary Outcome Measures

Failure of method
Defined as a necessity of re-intervention (endoscopic, surgical, percutaneous) within the period following LAMS insertion and before its planned extraction due to complications related to LAMS insertion and/or clinical deterioration.
Mortality
Overall mortality during subsequent follow-up

Secondary Outcome Measures

Clinical success rate
Resolution of the collection and symptoms following endoscopic drainage with LAMS before its extraction.
Adverse events
Primarily complications caused by LAMS itself (bleeding due to vessel erosion, secondary infection due to stent obstruction, stent migration, buried stent syndrome).
Number of procedures
Number of forced endoscopic interventions (direct endoscopic necrosectomy, debridement, desobliteration, etc.) required to achieve resolution.
Hospital stay
Total length of hospital stay within the period following LAMS insertion until its extraction.
Recurrence rate
Recurrence of the collection accompanied by symptoms provided there had been previous clinical success with documented resolution of the collection by radiological studies.
Microbiological cultivation
Material from the collection will be collected at every endoscopic intervention (at least during insertion and extraction of LAMS) to assess colonization by microbial flora over time.

Full Information

First Posted
April 12, 2019
Last Updated
April 1, 2023
Sponsor
Palacky University
search

1. Study Identification

Unique Protocol Identification Number
NCT03923686
Brief Title
Lumen-apposing Metal Stent With or Without Coaxial Plastic Stent for Treatment of Walled-off Pancreatic Necrosis
Official Title
Endoscopic Ultrasound-guided Drainage Using Lumen-apposing Metal Stent With or Without Coaxial Plastic Stent for Treatment of Walled-off Pancreatic Necrosis: a Prospective Randomised Study
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Completed
Study Start Date
May 13, 2019 (Actual)
Primary Completion Date
December 31, 2021 (Actual)
Study Completion Date
December 31, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Palacky University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
A prospective randomized cohort study to compare whether the placement of a double-pigtail plastic stent (DPS) within a lumen-apposing metal stent (LAMS) may improve the efficacy and safety of endoscopic ultrasound guided transmural drainage of walled-off pancreatic necrosis (WON) and thus prevent potential adverse events related to LAMS insertion.
Detailed Description
The aim of the study is to compare endoscopic ultrasound guided transmural drainage using lumen-apposing metal stent with (1.) or without (2.) coaxial plastic stent in the management of walled-off pancreatic necrosis. The usage of LAMS has been evaluated as a safe and effective method for the drainage of walled-off pancreatic necrosis in various studies. However, complications such as bleeding, infection due to stent obstruction, stent migration, or buried stent syndrome have been reported. A preventive measure to minimize adverse events related to LAMS insertion by means of placing an anchoring DPS through the LAMS have been suggested but there has been no prospective randomized study to assess the utility of such measure to date. The study is to be conducted at a tertiary institution with an expertise in treating hepato-pancreato-biliary diseases. The main timeframe of the study is 3 weeks following LAMS insertion with or without DPS. All LAMS will be extracted 3 weeks after the initial procedure. The extraction will be preceded by a CT scan of the abdomen to assess whether the DPS needs to be left in place/ inserted in patients with incomplete resolution of the collection. In addition, material from the collection will be collected for cultivation at every endoscopic intervention to assess colonization by microbial flora over time. All patients will be closely followed with clinical, laboratory, and radiological assessment for 12 months in total. Our experience has shown failure of the (2.) method in 70 % of patients so far. Assuming a clinically significant difference to be a reduction to 40 % in failed patients using the (1) method, the required study population size was calculated to 62 patients (31 in both arms) by power analysis (at standard alpha and beta values). The final number was set to 70 as a safety measure.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pancreatitis, Acute Necrotizing, Walled Off Necrosis
Keywords
Walled off necrosis, Acute pancreatitis, Necrotizing pancreatitis, Endoscopic drainage, Lumen apposing metal stents, Double pigtail plastic stent

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
a prospective randomized cohort study
Masking
None (Open Label)
Allocation
Randomized
Enrollment
67 (Actual)

8. Arms, Groups, and Interventions

Arm Title
LAMS plus DPS
Arm Type
Experimental
Arm Description
Endoscopic ultrasound-guided (EUS) transmural drainage of walled-off pancreatic necrosis (WON) using lumen-apposing metal stent (LAMS) with coaxial double-pigtail plastic stent (DPS).
Arm Title
LAMS alone
Arm Type
Active Comparator
Arm Description
Endoscopic ultrasound-guided (EUS) transmural drainage of walled-off pancreatic necrosis (WON) using lumen-apposing metal stent (LAMS) alone.
Intervention Type
Procedure
Intervention Name(s)
EUS-guided drainage using LAMS with DPS
Intervention Description
Endoscopic ultrasound-guided drainage using lumen-apposing metal stent with coaxial plastic stent in the treatment of walled-off pancreatic necrosis.
Intervention Type
Procedure
Intervention Name(s)
EUS-guided drainage using LAMS alone
Intervention Description
Endoscopic ultrasound-guided drainage using lumen-apposing metal stent without coaxial plastic stent in the treatment of walled-off pancreatic necrosis.
Primary Outcome Measure Information:
Title
Failure of method
Description
Defined as a necessity of re-intervention (endoscopic, surgical, percutaneous) within the period following LAMS insertion and before its planned extraction due to complications related to LAMS insertion and/or clinical deterioration.
Time Frame
up to 1 month
Title
Mortality
Description
Overall mortality during subsequent follow-up
Time Frame
up to 12 months
Secondary Outcome Measure Information:
Title
Clinical success rate
Description
Resolution of the collection and symptoms following endoscopic drainage with LAMS before its extraction.
Time Frame
up to 1 month
Title
Adverse events
Description
Primarily complications caused by LAMS itself (bleeding due to vessel erosion, secondary infection due to stent obstruction, stent migration, buried stent syndrome).
Time Frame
up to 1 month
Title
Number of procedures
Description
Number of forced endoscopic interventions (direct endoscopic necrosectomy, debridement, desobliteration, etc.) required to achieve resolution.
Time Frame
up to 1 month
Title
Hospital stay
Description
Total length of hospital stay within the period following LAMS insertion until its extraction.
Time Frame
up to 1 month
Title
Recurrence rate
Description
Recurrence of the collection accompanied by symptoms provided there had been previous clinical success with documented resolution of the collection by radiological studies.
Time Frame
up to 12 months
Title
Microbiological cultivation
Description
Material from the collection will be collected at every endoscopic intervention (at least during insertion and extraction of LAMS) to assess colonization by microbial flora over time.
Time Frame
up to 1 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: walled-off pancreatic necrosis (WON) indicated for endoscopical drainage signed informed consent form Exclusion Criteria: patient disagreement with the study types of collections other than WON drainage with stents other than LAMS previous attempts at drainage of WON severe coagulopathy or thrombocytopenia
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Petr Vanek, MD
Organizational Affiliation
Assistant Professor, physician
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Olomouc, Second Department of Internal Medicine - Gastroenterology and Geriatrics
City
Olomouc
ZIP/Postal Code
77900
Country
Czechia

12. IPD Sharing Statement

Learn more about this trial

Lumen-apposing Metal Stent With or Without Coaxial Plastic Stent for Treatment of Walled-off Pancreatic Necrosis

We'll reach out to this number within 24 hrs